CNN-NP flashcards
CNN-NP · Build recall with a focused review session.
32 cards. Read the term and the definition here. The deck at the top of this page is optional.
- CKD definition
- Abnormalities of kidney structure or function present for more than 3 months with health implications, including eGFR below 60 mL/min/1.73 m2 or markers of kidney damage such as albuminuria.
- KDIGO GFR categories
- G1 is 90 or higher, G2 is 60-89, G3a is 45-59, G3b is 30-44, G4 is 15-29, and G5 is below 15 mL/min/1.73 m2.
- Albuminuria categories
- A1 is less than 30 mg/g, A2 is 30-300 mg/g, and A3 is greater than 300 mg/g on spot urine albumin-to-creatinine ratio; confirm persistent elevation with repeat testing.
- AKI KDIGO criteria
- Creatinine rise of 0.3 mg/dL or more within 48 hours, or 1.5 times baseline within 7 days, or urine output below 0.5 mL/kg/h for 6 hours.
- CKD-EPI 2021 equation
- Race-free creatinine-based equation used to estimate GFR; it replaced the 2009 equation that included a race coefficient, and cystatin C can be added for confirmation.
- Hyperkalemia emergency treatment
- Give IV calcium for membrane stabilization when ECG changes are present, then insulin with glucose or albuterol to shift potassium, then remove potassium with diuretics, binders, or dialysis.
- CKD metabolic acidosis
- Usually a normal-anion-gap acidosis; oral sodium bicarbonate is considered when serum bicarbonate is below 18-22 mEq/L, with monitoring for sodium retention and hypokalemia.
- Anemia of CKD
- Normocytic normochromic anemia; check iron studies before starting an ESA, and do not initiate ESA when hemoglobin is 10 g/dL or higher.
- Peritoneal dialysis peritonitis
- Suspected with cloudy effluent, abdominal pain, or fever; diagnosis needs effluent WBC above 100/mm3 with more than 50% neutrophils plus culture, and empiric intraperitoneal antibiotics cover gram-positive and gram-negative organisms.
- Hemodialysis adequacy Kt/V
- A common target is single-pool Kt/V of at least 1.2 per session for thrice-weekly hemodialysis, equivalent to a urea reduction ratio of at least 65%.
- AV fistula rule of 6s
- A mature fistula has blood flow above 600 mL/min, diameter above 0.6 cm, and depth below 0.6 cm; maturation usually takes 6-8 weeks before first cannulation.
- Dialysis disequilibrium syndrome
- Headache, nausea, confusion, seizures, or coma during or after dialysis; prevention uses slower blood flow, shorter initial sessions, and higher sodium dialysate in high-risk patients.
- Intradialytic hypotension
- Systolic BP fall of 20 mmHg or more or MAP fall of 10 mmHg or more with symptoms during dialysis; assess dry weight, ultrafiltration rate, and antihypertensive timing.
- Nephrotic syndrome features
- Proteinuria above 3.5 g/day, hypoalbuminemia, edema, and hyperlipidemia; complications include thrombosis, infection, and vitamin D deficiency.
- Nephritic syndrome features
- Hematuria with dysmorphic RBCs and RBC casts, hypertension, oliguria, and variable proteinuria; post-streptococcal GN shows low C3 after pharyngitis or impetigo.
- IgA nephropathy
- The most common primary glomerulonephritis worldwide; it presents with episodic gross hematuria after upper respiratory infection, and serum complement is typically normal.
- Minimal change disease
- The most common nephrotic syndrome in children; light microscopy is normal, electron microscopy shows podocyte foot process effacement, and it usually responds to corticosteroids.
- Membranous nephropathy
- A common cause of nephrotic syndrome in older adults, often associated with anti-PLA2R antibodies, with a high risk of thrombotic complications.
- Rapidly progressive GN
- Declining GFR over days to weeks with crescents on biopsy; anti-GBM disease and ANCA-associated vasculitis are key causes requiring urgent nephrology involvement.
- Hyponatremia correction limits
- Correct no more than 8-10 mEq/L in 24 hours and 18 mEq/L in 48 hours to reduce osmotic demyelination risk; use 3% saline with frequent sodium checks in symptomatic cases.
- Hypernatremia correction limit
- Correct no more than 10-12 mEq/L per 24 hours to avoid cerebral edema; free water deficit equals total body water times (serum sodium divided by 140 minus 1).
- Hypokalemia ECG changes
- Flattened T waves, ST depression, and prominent U waves; severe hypokalemia can cause rhabdomyolysis, ileus, and arrhythmias.
- Tumor lysis syndrome
- Hyperkalemia, hyperphosphatemia, hyperuricemia, and hypocalcemia; prevention uses hydration and allopurinol or rasburicase for high-risk patients.
- Rhabdomyolysis management
- CK elevation with myoglobinuria, dark urine, and AKI; treat with aggressive IV fluids and monitor for hyperkalemia and hypocalcemia.
- Tacrolimus monitoring
- Requires therapeutic drug monitoring; trough goals vary by time post-transplant and rejection risk, and nephrotoxicity plus tremor are common adverse effects.
- BK polyomavirus nephropathy
- Monitor plasma BK viral load after transplant; sustained high viral load warrants reducing immunosuppression, and biopsy is used to confirm.
- CMV prophylaxis after transplant
- Valganciclovir prophylaxis for high-risk serostatus, especially donor-positive recipient-negative; active disease presents with fever, leukopenia, and organ involvement.
- FENa formula
- Fractional excretion of sodium equals (urine sodium times serum creatinine) divided by (serum sodium times urine creatinine), multiplied by 100; below 1% suggests a prerenal state.
- RBC casts meaning
- Red blood cell casts indicate glomerular bleeding; WBC casts suggest pyelonephritis or interstitial nephritis, and muddy brown casts suggest acute tubular necrosis.
- BUN-to-creatinine ratio
- A ratio above 20:1 suggests prerenal azotemia or upper GI bleeding; a ratio of 10:1 to 20:1 is typical of normal kidney function.
- SGLT2 inhibitors in CKD
- Dapagliflozin and empagliflozin reduce CKD progression and heart failure hospitalization in CKD with or without diabetes; eGFR decline of up to 30% after initiation is acceptable.
- Nephrotoxic drug avoidance
- Avoid NSAIDs in CKD, especially with ACE inhibitors or ARBs and diuretics; they cause afferent arteriolar vasoconstriction and AKI. Metformin is contraindicated when eGFR is below 30.